Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's lymphoma

被引：0
|
作者：
Eich, HT
Müller, RP
Engert, A
Wolf, J
Hansemann, K
Pfistner, B
Diehl, V
机构：
[1] Univ Klinikum Koln, Klin & Poliklin Strahlentherapie, Cologne, Germany
[2] Univ Klinikum Koln, Innere Med Klin 1, Cologne, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2004年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [1] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's lymphoma: Interim analysis of the German Hodgkin study group trial HDIO
    Eich, H
    Mueller, R
    Engert, A
    Hansemann, K
    Skripnitchenko, R
    Pfistner, B
    Lukas, P
    Willich, N
    Diehl, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S1 - S2
  • [2] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's disease:: interim results of the German Hodgkin's Lymphoma Study Group (GHSG) trial hd10
    Müller, RP
    Eich, HT
    Wolf, J
    Pfistner, B
    Engert, A
    Diehl, V
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S205 - S205
  • [3] Results of the 4th interim analysis of the HID 11 trial of the GHSG for intermediate stage Hodgkin's lymphoma:: 30 Gy versus 20 Gy involved field radiotherapy
    Eich, HT
    Müller, RP
    Hansemann, K
    Engert, A
    Pfistner, B
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 49 - 49
  • [4] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) is the New Standard of Care in the Treatment of Patients with Early Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) Trial HD10
    Mueller, R. P.
    Eich, H. T.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilbom, K.
    Eble, M.
    Mueller-Hennelink, H.
    Diehl, V.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S26 - S27
  • [5] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10.
    Engert, Andreas
    Diehl, Volker
    Pluetschow, Annette
    Eich, Hans T.
    Herrmann, Richard
    Doerken, Bernd
    Kanz, Lothar
    Greil, Richard
    Markova, Jana
    Fuchs, Michael
    Borchmann, Peter
    Mueller-Hermelink, Hans Konrad
    Mueller, Rolf Peter
    BLOOD, 2009, 114 (22) : 299 - 299
  • [6] Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs 40 Gy extended field radiotherapy alone
    Duhmke, E
    Diehl, V
    Loeffler, M
    Mueller, RP
    Ruehl, U
    Willich, N
    Georgii, A
    Roth, S
    Matthaei, D
    Sehlen, S
    Brosteanu, O
    Hasenclever, D
    Wilkowski, R
    Becker, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (02): : 305 - 310
  • [7] Two cycles of ABVD followed by involved field radiotherapy with 20 Gray (Gy) is the new standard of care in the treatment of patients with early-stage Hodgkin lymphoma: final analysis of the randomized German Hodgkin Study Group (GHSG) HD10 study
    Engert, A.
    Diehl, V
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermeling, H. K.
    Mueller, R. P.
    ONKOLOGIE, 2010, 33 : 124 - 124
  • [8] TWO CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD RADIOTHERAPY WITH 20 GRAY (GY) IS THE NEW STANDARD OF CARE IN THE TREATMENT OF PATIENTS WITH EARLY-STAGE HODGKIN LYMPHOMA: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) HD10 STUDY
    Engert, A.
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermelink, H.
    Mueller, R.
    Diehl, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 473 - 473
  • [9] Intermediate stage Hodgkin's disease:: Preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapy
    Anselmo, AP
    Cavalieri, E
    Osti, FM
    Cantonetti, M
    De Sanctis, V
    Alfo, M
    Amadori, S
    Enrici, RM
    ANTICANCER RESEARCH, 2004, 24 (06) : 4045 - 4050
  • [10] FAVORABLE EARLY STAGE HODGKIN LYMPHOMA TREATED WITH 2 CYCLES OF ABVD PLUS INVOLVED-SITE RADIOTERAPY 20 GY: INITIAL VERY GOOD RESULTS IN "REAL-LIFE"
    Nicolosi, M.
    Levis, M.
    Gavarotti, P.
    Piva, C.
    Bernocco, E.
    Botto, B.
    Filippi, A. R.
    Pregno, P.
    Vitolo, U.
    Ricardi, U.
    HAEMATOLOGICA, 2015, 100 : 88 - 89
12345